News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
560,921 Results
Type
Article (47183)
Company Profile (118)
Press Release (513605)
Multimedia
Podcasts (166)
Webinars (22)
Section
Business (145971)
Career Advice (2429)
Deals (28196)
Drug Delivery (163)
Drug Development (68704)
Employer Resources (160)
FDA (16106)
Job Trends (12100)
News (266124)
Policy (29938)
Tag
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2345)
Academic (1)
Accelerated approval (54)
Adcomms (40)
Allergies (164)
Alliances (36151)
ALS (204)
Alzheimer's disease (1839)
Antibody-drug conjugate (ADC) (463)
Approvals (16362)
Artificial intelligence (645)
Autoimmune disease (306)
Automation (46)
Bankruptcy (313)
Best Places to Work (9196)
BIOSECURE Act (23)
Biosimilars (223)
Biotechnology (68)
Bladder cancer (199)
Brain cancer (70)
Breast cancer (705)
Cancer (5613)
Cardiovascular disease (492)
Career advice (2067)
Career pathing (47)
CAR-T (302)
CDC (76)
Celiac Disease (2)
Cell therapy (876)
Cervical cancer (46)
Clinical research (60229)
Collaboration (1816)
Company closure (7)
Compensation (1412)
Complete response letters (102)
COVID-19 (2754)
CRISPR (107)
C-suite (1066)
Cystic fibrosis (152)
Data (7594)
Decentralized trials (3)
Denatured (37)
Depression (180)
Dermatology (88)
Diabetes (564)
Diagnostics (5763)
Digital health (46)
Diversity (7)
Diversity, equity & inclusion (43)
Drug discovery (290)
Drug pricing (239)
Drug shortages (34)
Duchenne muscular dystrophy (298)
Earnings (64240)
Editorial (78)
Employer branding (20)
Employer resources (142)
Events (84305)
Executive appointments (999)
FDA (19842)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (32)
Funding (1510)
Gene editing (234)
Generative AI (57)
Gene therapy (736)
GLP-1 (1167)
Government (4281)
Grass and pollen (8)
Guidances (399)
Healthcare (15074)
HIV (82)
Huntington's disease (60)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (104)
Immunology and inflammation (336)
Immuno-oncology (92)
Indications (179)
Infectious disease (3090)
Inflammatory bowel disease (211)
Inflation Reduction Act (14)
Influenza (125)
Intellectual property (280)
Interviews (457)
IPO (14161)
IRA (58)
Job creations (3178)
Job search strategy (1676)
JPM (69)
Kidney cancer (21)
Labor market (104)
Layoffs (640)
Leadership (50)
Legal (7022)
Liver cancer (100)
Longevity (25)
Lung cancer (731)
Lymphoma (411)
Machine learning (56)
Management (52)
Manufacturing (978)
MASH (207)
Medical device (11739)
Medtech (11852)
Mergers & acquisitions (15190)
Metabolic disorders (1581)
mRNA (235)
Multiple sclerosis (171)
NASH (23)
Neurodegenerative disease (432)
Neuropsychiatric disorders (118)
Neuroscience (3344)
Neurotech (2)
NextGen: Class of 2026 (5001)
Non-profit (3207)
Now hiring (34)
Obesity (784)
Opinion (309)
Ovarian cancer (210)
Pain (238)
Pancreatic cancer (300)
Parkinson's disease (366)
Partnered (26)
Patents (580)
Patient recruitment (656)
Peanut (59)
People (44925)
Pharmaceutical (34)
Pharmacy benefit managers (35)
Phase 1 (18084)
Phase 2 (26095)
Phase 3 (21308)
Pipeline (8537)
Policy (383)
Postmarket research (2213)
Preclinical (7359)
Press Release (28)
Prostate cancer (313)
Psychedelics (65)
Radiopharmaceuticals (294)
Rare diseases (1141)
Real estate (4314)
Recruiting (65)
Regulatory (24190)
Reports (47)
Research institute (2141)
Resumes & cover letters (405)
Rett syndrome (39)
RNA editing (22)
RSV (83)
Schizophrenia (185)
Series A (261)
Series B (196)
Service/supplier (8)
Sickle cell disease (113)
Special edition (30)
Spinal muscular atrophy (149)
Sponsored (52)
Startups (2816)
State (1)
Stomach cancer (21)
Supply chain (127)
Tariffs (104)
The Weekly (127)
Vaccines (1196)
Venture capital (121)
Weight loss (554)
Women's health (109)
Worklife (24)
Date
Today (130)
Last 7 days (587)
Last 30 days (3223)
Last 365 days (28405)
2026 (12689)
2025 (28393)
2024 (31393)
2023 (34981)
2022 (45060)
2021 (48495)
2020 (45509)
2019 (36212)
2018 (27394)
2017 (27810)
2016 (25803)
2015 (27974)
2014 (21777)
2013 (17793)
2012 (18968)
2011 (19381)
2010 (17506)
Location
Africa (691)
Alabama (74)
Alaska (6)
Arizona (271)
Arkansas (12)
Asia (32792)
Australia (5769)
California (12507)
Canada (2925)
China (1128)
Colorado (489)
Connecticut (558)
Delaware (375)
Europe (80511)
Florida (1898)
Georgia (387)
Hawaii (4)
Idaho (40)
Illinois (927)
India (75)
Indiana (500)
Iowa (23)
Japan (525)
Kansas (111)
Kentucky (36)
Louisiana (31)
Maine (77)
Maryland (1509)
Massachusetts (9004)
Michigan (301)
Minnesota (649)
Mississippi (5)
Missouri (133)
Montana (13)
Nebraska (23)
Nevada (132)
New Hampshire (64)
New Jersey (3315)
New Mexico (16)
New York (3211)
North Carolina (1587)
North Dakota (8)
Northern California (6389)
Ohio (342)
Oklahoma (17)
Oregon (34)
Pennsylvania (2377)
Puerto Rico (22)
Rhode Island (33)
South America (1048)
South Carolina (83)
South Dakota (2)
Southern California (4918)
Tennessee (183)
Texas (1913)
United States (43438)
Utah (312)
Virginia (301)
Washington D.C. (73)
Washington State (973)
West Virginia (4)
Wisconsin (128)
Wyoming (1)
560,921 Results for "almirall prodesfarma s a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Almirall’s 2025 Results
February 23, 2026
·
9 min read
Press Releases
Almirall’s 2025 9M Results
November 10, 2025
·
7 min read
Press Releases
Evotec Announces Nomination of First Preclinical Development Candidate in Dermatology Collaboration with Almirall
May 4, 2026
·
5 min read
Press Releases
Almirall and Barcelona Supercomputing Center Expand Their Collaboration to Accelerate Innovation in Medical Dermatology
April 13, 2026
·
6 min read
Press Releases
Almirall Inaugurates Offices in China to Advance Innovation in Medical Dermatology Through Partnerships
March 12, 2026
·
7 min read
Press Releases
Almirall Continues Its Positive Trajectory in Q1 2026 in Line With Expectations – Led by 19.3% YoY Growth of Its European Dermatology Business
May 11, 2026
·
8 min read
Press Releases
AAD 2026: Almirall Presents New Clinical and Real‑world Evidence Across Atopic Dermatitis, Psoriasis, Actinic Keratosis and Acne
March 26, 2026
·
14 min read
Press Releases
Almirall Announces the Approval of Seysara® in China for the Treatment of Moderate-to-Severe Acne
January 29, 2026
·
8 min read
Press Releases
Almirall Announces “LumiNE”, a Phase III Clinical Study Assessing the Efficacy of Lebrikizumab for the Treatment of Nummular Eczema
January 16, 2026
·
7 min read
Press Releases
Almirall’s 17th Skin Academy Highlights Scientific Advances in Inflammatory Skin Diseases and Skin Cancer, Patient-Reported Outcomes, and Holistic Care in Medical Dermatology
March 23, 2026
·
7 min read
1 of 56,093
Next
